Zenabis, Canada’s largest indoor licensed producer of medical cannabis, has just announced that they have signed a letter of intent (LOI) to become a preferred medical cannabis supplier to Pharmasave.
The letter of intent will allow the company to supply and distribute medical cannabis through Pharmasave locations across Canada.
The deal would be coupled with providing education to pharmacists and cannabis-specific training.
Pharamasave currently owns and operates more than 650 independent community pharmacies across Canada. The goal of Pharmasave is to allow their pharmacists to work with patients and physicians to keep reaching optimal health outcomes.
Kevin Coft, CEO, shares that “having their products available in pharmacies across Canada brings Zenabis closer to its goal of building towards being the largest privately-held enterprise in the Canadian cannabis sector”.
Zenabis currently has two facilities in both British Columbia and New Brunswick, with 400,000 square feet of space for indoor cultivation.